Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Down 24.6% in December

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 13,200 shares, a decrease of 24.6% from the November 30th total of 17,500 shares. Based on an average daily volume of 27,200 shares, the short-interest ratio is currently 0.5 days.

Reviva Pharmaceuticals Stock Down 14.3 %

Shares of RVPHW stock traded down $0.03 on Friday, hitting $0.18. 20,319 shares of the stock were exchanged, compared to its average volume of 20,192. Reviva Pharmaceuticals has a one year low of $0.07 and a one year high of $1.62. The firm’s 50 day moving average is $0.19 and its two-hundred day moving average is $0.18.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.